These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38727597)
1. A novel multi-epitope peptide vaccine candidate targeting hepatitis E virus: An in silico approach. Kumar A; Sahu U; Agnihotri G; Dixit A; Khare P J Viral Hepat; 2024 Aug; 31(8):446-456. PubMed ID: 38727597 [TBL] [Abstract][Full Text] [Related]
2. Characterization of Three Novel Linear Neutralizing B-Cell Epitopes in the Capsid Protein of Swine Hepatitis E Virus. Chen Y; Liu B; Sun Y; Li H; Du T; Nan Y; Hiscox JA; Zhou EM; Zhao Q J Virol; 2018 Jul; 92(13):. PubMed ID: 29669835 [TBL] [Abstract][Full Text] [Related]
3. Design and production of a multiepitope construct derived from hepatitis E virus capsid protein. Taherkhani R; Farshadpour F; Makvandi M J Med Virol; 2015 Jul; 87(7):1225-34. PubMed ID: 25784455 [TBL] [Abstract][Full Text] [Related]
4. T-cell epitope mapping of ORF2 and ORF3 proteins of human hepatitis E virus. Aggarwal R; Shukla R; Jameel S; Agrawal S; Puri P; Gupta VK; Patil AP; Naik S J Viral Hepat; 2007 Apr; 14(4):283-92. PubMed ID: 17381721 [TBL] [Abstract][Full Text] [Related]
5. Specific memory B cell response and participation of CD4 Kulkarni SP; Thanapati S; Arankalle VA; Tripathy AS Vaccine; 2016 Nov; 34(48):5895-5902. PubMed ID: 27997340 [TBL] [Abstract][Full Text] [Related]
6. Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus. Fadaka AO; Sibuyi NRS; Martin DR; Goboza M; Klein A; Madiehe AM; Meyer M Sci Rep; 2021 Oct; 11(1):19707. PubMed ID: 34611250 [TBL] [Abstract][Full Text] [Related]
7. Characterization of Two Novel Linear B-Cell Epitopes in the Capsid Protein of Avian Hepatitis E Virus (HEV) That Are Common to Avian, Swine, and Human HEVs. Wang X; Zhao Q; Dang L; Sun Y; Gao J; Liu B; Syed SF; Tao H; Zhang G; Luo J; Zhou EM J Virol; 2015 May; 89(10):5491-501. PubMed ID: 25741007 [TBL] [Abstract][Full Text] [Related]
8. A Recombinant HAV Expressing a Neutralization Epitope of HEV Induces Immune Response against HAV and HEV in Mice. Xiang K; Kusov Y; Ying G; Yan W; Shan Y; Jinyuan W; Na Y; Yan Z; Hongjun L; Maosheng S Viruses; 2017 Sep; 9(9):. PubMed ID: 28914805 [TBL] [Abstract][Full Text] [Related]
9. Toward the development of a hepatitis E vaccine. Kamili S Virus Res; 2011 Oct; 161(1):93-100. PubMed ID: 21620908 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic Hepatitis E Vaccines: Antigenic Analysis and Serological Evaluation. Li Y; Huang X; Zhang Z; Li S; Zhang J; Xia N; Zhao Q Viruses; 2020 Jan; 12(1):. PubMed ID: 31963175 [TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice. Deshmukh TM; Lole KS; Tripathy AS; Arankalle VA Vaccine; 2007 May; 25(22):4350-60. PubMed ID: 17459540 [TBL] [Abstract][Full Text] [Related]
12. Generation in yeast and antigenic characterization of hepatitis E virus capsid protein virus-like particles. Simanavicius M; Tamosiunas PL; Petraityte-Burneikiene R; Johne R; Ulrich RG; Zvirbliene A; Kucinskaite-Kodze I Appl Microbiol Biotechnol; 2018 Jan; 102(1):185-198. PubMed ID: 29143081 [TBL] [Abstract][Full Text] [Related]
13. Computational design of experimentally validated multi-epitopes vaccine against hepatitis E virus: An immunological approach. Anwar T; Ismail S; Parvaiz F; Abbasi SW; A Al-Abbasi F; M Alghamdi A; Al-Regaiey K; Ul-Haq A; Kaleem I; Bashir S; Waheed Y PLoS One; 2023; 18(12):e0294663. PubMed ID: 38096182 [TBL] [Abstract][Full Text] [Related]
14. Reverse Vaccinology and Immunoinformatic Approach for Designing a Bivalent Vaccine Candidate Against Hepatitis A and Hepatitis B Viruses. Ahmadi N; Aghasadeghi M; Hamidi-Fard M; Motevalli F; Bahramali G Mol Biotechnol; 2024 Sep; 66(9):2362-2380. PubMed ID: 37715882 [TBL] [Abstract][Full Text] [Related]
15. [Selection of a peptide mimic the neutralization epitope of hepatitis E virus with phage peptide display technology]. Gu Y; Zhang J; Wang YB; Li SW; Yang HJ; Luo WX; Xia NS Sheng Wu Gong Cheng Xue Bao; 2003 Nov; 19(6):680-5. PubMed ID: 15971579 [TBL] [Abstract][Full Text] [Related]
16. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy. Sridhar S; Situ J; Cai JP; Yip CC; Wu S; Zhang AJ; Wen L; Chew NF; Chan WM; Poon RW; Chan JF; Tsang DN; Chen H; Xia NS; Yuen KY J Hepatol; 2021 Jun; 74(6):1315-1324. PubMed ID: 33845058 [TBL] [Abstract][Full Text] [Related]
17. Progress in the Production of Virus-Like Particles for Vaccination against Hepatitis E Virus. Mazalovska M; Kouokam JC Viruses; 2020 Jul; 12(8):. PubMed ID: 32751441 [TBL] [Abstract][Full Text] [Related]
18. Prophylactic Hepatitis E Vaccine. Zhang J; Zhao Q; Xia N Adv Exp Med Biol; 2016; 948():223-246. PubMed ID: 27738988 [TBL] [Abstract][Full Text] [Related]
19. Antigenic determinants of hepatitis E virus and vaccine-induced immunogenicity and efficacy. Zhao Q; Zhang J; Wu T; Li SW; Ng MH; Xia NS; Shih JW J Gastroenterol; 2013 Feb; 48(2):159-68. PubMed ID: 23149436 [TBL] [Abstract][Full Text] [Related]
20. Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice. Renoux VM; Fleury MJ; Bousarghin L; Gaitan J; Sizaret PY; Touzé A; Coursaget P Vaccine; 2008 Dec; 26(51):6602-7. PubMed ID: 18835319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]